These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26914463)

  • 1. Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function.
    Fonseca MI; Chu S; Pierce AL; Brubaker WD; Hauhart RE; Mastroeni D; Clarke EV; Rogers J; Atkinson JP; Tenner AJ
    PLoS One; 2016; 11(2):e0149792. PubMed ID: 26914463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.
    Johansson JU; Brubaker WD; Javitz H; Bergen AW; Nishita D; Trigunaite A; Crane A; Ceballos J; Mastroeni D; Tenner AJ; Sabbagh M; Rogers J
    Alzheimers Dement; 2018 Nov; 14(11):1438-1449. PubMed ID: 29792870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease.
    Mahmoudi R; Feldman S; Kisserli A; Duret V; Tabary T; Bertholon LA; Badr S; Nonnonhou V; Cesar A; Neuraz A; Novella JL; Cohen JHM
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease is associated with low density of the long CR1 isoform.
    Mahmoudi R; Kisserli A; Novella JL; Donvito B; Dramé M; Réveil B; Duret V; Jolly D; Pham BN; Cohen JH
    Neurobiol Aging; 2015 Apr; 36(4):1766.e5-1766.e12. PubMed ID: 25666996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer's disease.
    Kucukkilic E; Brookes K; Barber I; Guetta-Baranes T; ; Morgan K; Hollox EJ
    Hum Genet; 2018 Apr; 137(4):305-314. PubMed ID: 29675612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement receptor type 1 (CR1, CD35) is a receptor for C1q.
    Klickstein LB; Barbashov SF; Liu T; Jack RM; Nicholson-Weller A
    Immunity; 1997 Sep; 7(3):345-55. PubMed ID: 9324355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: a meta-analysis.
    Jin C; Li W; Yuan J; Xu W; Cheng Z
    Neurosci Lett; 2012 Oct; 527(1):46-9. PubMed ID: 22960360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Report of CR1 Polymorphisms and Soluble CR1 Levels Associated with Late Onset Alzheimer's Disease (LOAD) in Latin America.
    Kretzschmar GC; Antoniazzi AAH; Oliveira LC; Nisihara RM; Petzl-Erler ML; de Souza RLR; Boldt ABW
    J Mol Neurosci; 2020 Sep; 70(9):1338-1344. PubMed ID: 32388800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism.
    Hazrati LN; Van Cauwenberghe C; Brooks PL; Brouwers N; Ghani M; Sato C; Cruts M; Sleegers K; St George-Hyslop P; Van Broeckhoven C; Rogaeva E
    Neurobiol Aging; 2012 Dec; 33(12):2949.e5-2949.e12. PubMed ID: 22819390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer's disease and related endophenotypes.
    Van Cauwenberghe C; Bettens K; Engelborghs S; Vandenbulcke M; Van Dongen J; Vermeulen S; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Sleegers K
    Neurobiol Aging; 2013 Sep; 34(9):2235.e1-6. PubMed ID: 23582656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.
    Birmingham DJ; Chen W; Liang G; Schmitt HC; Gavit K; Nagaraja HN
    Immunology; 2003 Apr; 108(4):531-8. PubMed ID: 12667215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement receptor 1 (CR1) and Alzheimer's disease.
    Crehan H; Holton P; Wray S; Pocock J; Guerreiro R; Hardy J
    Immunobiology; 2012 Feb; 217(2):244-50. PubMed ID: 21840620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential complement activation pathways promote C3b deposition on native and acetylated LDL thereby inducing lipoprotein binding to the complement receptor 1.
    Klop B; van der Pol P; van Bruggen R; Wang Y; de Vries MA; van Santen S; O'Flynn J; van de Geijn GJ; Njo TL; Janssen HW; de Man P; Jukema JW; Rabelink TJ; Rensen PC; van Kooten C; Cabezas MC
    J Biol Chem; 2014 Dec; 289(51):35421-30. PubMed ID: 25349208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
    Subramanian VB; Clemenza L; Krych M; Atkinson JP
    J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CR1 is associated with amyloid plaque burden and age-related cognitive decline.
    Chibnik LB; Shulman JM; Leurgans SE; Schneider JA; Wilson RS; Tran D; Aubin C; Buchman AS; Heward CB; Myers AJ; Hardy JA; Huentelman MJ; Corneveaux JJ; Reiman EM; Evans DA; Bennett DA; De Jager PL
    Ann Neurol; 2011 Mar; 69(3):560-9. PubMed ID: 21391232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Updated Analysis with 85,939 Samples Confirms the Association Between CR1 rs6656401 Polymorphism and Alzheimer's Disease.
    Shen N; Chen B; Jiang Y; Feng R; Liao M; Zhang L; Li F; Ma G; Chen Z; Zhao B; Li K; Liu G
    Mol Neurobiol; 2015; 51(3):1017-23. PubMed ID: 24878768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.
    Zhu XC; Wang HF; Jiang T; Lu H; Tan MS; Tan CC; Tan L; Tan L; Yu JT;
    Mol Neurobiol; 2017 Jan; 54(1):551-562. PubMed ID: 26742530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer's disease.
    Zhu XC; Dai WZ; Ma T
    BMC Med Genet; 2020 Sep; 21(1):181. PubMed ID: 32919460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease-associated complement gene variants influence plasma complement protein levels.
    Veteleanu A; Stevenson-Hoare J; Keat S; Daskoulidou N; Zetterberg H; Heslegrave A; Escott-Price V; Williams J; Sims R; Zelek WM; Carpanini SM; Morgan BP
    J Neuroinflammation; 2023 Jul; 20(1):169. PubMed ID: 37480051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.